FDA’s top drug regulator resigns
Digest more
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...
Novo Nordisk narrowed its earnings guidance as intensifying competition, pricing pressure and copycat versions of its ...
Six people have died and 25 people have been hospitalized due to a listeria outbreak linked to now-recalled precooked pasta ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback